Recently, full data from the Phase II IDeate-Lung01 study on the antibody-drug conjugate I-DXd in previously treated extensive-stage small-cell lung cancer (ES-SCLC) were publish...
On July 28, 2025 — World Hepatitis Day — Bangladesh-based Beacon Pharmaceuticals officially introduced Sofosvel, the world’s first generic version of Epclusa (SOF/VEL). This mil...